ALEXANDER NGUYEN: Open Payments
NPI 1235846213 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 63 payments from 18 companies in 2025. Trend: 2023 $900 · 2024 $1,640 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $202 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Lilly USA, LLC | 7 | $119 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| PFIZER INC. | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $76 |
| Amgen Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
Products named: Ozempic, Kerendia, MOUNJARO, JARDIANCE, Wegovy, GEMTESA, ELIQUIS, FARXIGA.
Industry payments across VA — which companies pay providers there.
